Illumina news from FierceBiotech
NewsIllumina snares sequencing tech in $60M buyout
Illumina has struck a $60 million deal to enhance its genetic sequencing technology with the acquisition of Avantome. Avantome's owners will get $25 million of that upfront with the rest coming in Read more...
SPOTLIGHT: Illumina shells out $90M in settlement
San Diego-based Illumina will pay out $90 million to settle patent litigation with Affymetrix. Read more...
Illumina focuses on molecular diagnostics
San Diego-based Illumina has created two new business units. The Life Sciences Business Unit will include all products and services related to the company's sequencing and genotyping business. And Read more...
| Press ReleasesIllumina Creates Two New Business Units Illumina Creates Two New Business Units SAN DIEGO -- Illumina today announced that it has reorganized its operating structure to further leverage the synergies between its sequencing and genotyping Read more... |
Get more Illumina coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets